CN1096680A - The medicine of treatment cerebrovascular - Google Patents
The medicine of treatment cerebrovascular Download PDFInfo
- Publication number
- CN1096680A CN1096680A CN93107114A CN93107114A CN1096680A CN 1096680 A CN1096680 A CN 1096680A CN 93107114 A CN93107114 A CN 93107114A CN 93107114 A CN93107114 A CN 93107114A CN 1096680 A CN1096680 A CN 1096680A
- Authority
- CN
- China
- Prior art keywords
- medicine
- cerebrovascular
- chinese patent
- thoroughly
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The medicine of treatment cerebrovascular belongs to Chinese patent medicine.The medicine of existing treatment cerebrovascular, curative effect is all not obvious, can only play mitigation, can not thoroughly effect a radical cure.Chinese patent medicine of the present invention is made up of Rhizoma Coptidis, Radix Scutellariae, Radix Curcumae, Realgar, Cinnabaris, Borneolum Syntheticum, Styrax, Agkistrodon, bile, Cornu Bubali, bud powder, Placenta Hominis, mustard seed, Fructus Lycii.This Chinese patent medicine can thoroughly effect a radical cure hypertension, cerebrovascular disease, and hemiplegia, rheumatic arthritis, quadriplegia pain, apoplexy are also had obvious curative effects.The function of this medicine is activating blood circulation to dissipate blood stasis, eliminating fire and detoxication, inducing resuscitation, the thrombosis that disappears, blood fat reducing, dispelling wind and removing obstruction in the collateral.Generally about a week, just can thoroughly cure hypertension, patients with cerebrovascular disease.
Description
The medicine of treatment cerebrovascular belongs to Chinese patent medicine.
The medicine of existing treatment cerebrovascular, curative effect is all not obvious, can only play mitigation, can not thoroughly effect a radical cure.
The objective of the invention is to develop and a kind ofly can give medicine anti-and the treatment cerebrovascular, this medicine is to cerebrovascular and the thoroughly radical cure at short notice of hypertension condition of disease.
Medicine of the present invention is made up of Rhizoma Coptidis, Radix Scutellariae, Radix Curcumae, Realgar, Cinnabaris, Borneolum Syntheticum, Styrax, Agkistrodon, bile, Cornu Bubali, bud powder, Placenta Hominis, mustard seed, Fructus Lycii.Its weight ratio is: Rhizoma Coptidis 40～60g, Radix Scutellariae 35～55g, Radix Curcumae 46～59g, Realgar 45～60g, Cinnabaris 40～58g, Borneolum Syntheticum 15～35g, Styrax 18～38g, Agkistrodon 45～65g, bile 20～40g, Cornu Bubali 48～60g, bud powder 42～63g, Placenta Hominis 45～60g, mustard seed 40～50g, Fructus Lycii 20～38g.
Chinese patent medicine of the present invention has obvious therapeutic action to diseases such as hypertension, cerebrovascular, hemiplegia, headache, dizzinesses.Diseases such as hypertension, cerebrovascular can thoroughly be effected a radical cure, hemiplegia, rheumatic arthritis, quadriplegia pain, apoplexy are also had obvious curative effects.The function of this medicine is an activating blood circulation to dissipate blood stasis, eliminating fire and detoxication, inducing resuscitation, the thrombosis that disappears, blood fat reducing, dispelling wind and removing obstruction in the collateral.Generally about a week, just can thoroughly cure for hypertension, patients with cerebrovascular disease.
Embodiment: present embodiment selects Fructus Lycii 28g oven dry to pulverize.Select Rhizoma Coptidis 50g, Radix Scutellariae 48g, Radix Curcumae 52g, Realgar 51g, Cinnabaris 47g, Borneolum Syntheticum 24g, Styrax 26g, Agkistrodon 50g, Cornu Bubali 54g, Placenta Hominis 52g, mustard seed 49g, Rhizoma Gastrodiae 20～28g, Flos Carthami 22～30g, Lumbricus 20～30g, Concha Haliotidis 40～56g, Radix Ginseng 23～31g to pulverize.Selecting Ganoderma 46～52g, bud powder 55g, bile 30g, Mel 40～60g to refine into paste with decocting in water, is patent medicine with becoming pill with above medicated powder with mastic more together.
Claims (3)
1, the medicine of treatment cerebrovascular belongs to Chinese patent medicine, it is characterized in that it is made up of Rhizoma Coptidis, Radix Scutellariae, Radix Curcumae, Realgar, Cinnabaris, Borneolum Syntheticum, Styrax, Agkistrodon, bile, Cornu Bubali, bud powder, Placenta Hominis, mustard seed, Fructus Lycii.
2, the medicine of treatment cerebrovascular according to claim 1 is characterized in that the component weight ratio of medicine is: Rhizoma Coptidis 40～60g, Radix Scutellariae 35～55g, Radix Curcumae 46～59g, Realgar 45～60g, Cinnabaris 40～58g, bile 20～40g, Cornu Bubali 48～60g, bud powder 42～63g, Placenta Hominis 45～60g, mustard seed 40～50g, Fructus Lycii 20～38g.
3,, it is characterized in that this medicine also includes Ganoderma 46～52g, Rhizoma Gastrodiae 20～28g, Flos Carthami 22～30g, Lumbricus 20～30g, Concha Haliotidis 40～56g, Radix Ginseng 23～31g according to the medicine of claim 1,2 described treatment cerebrovascular.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93107114A CN1096680A (en) | 1993-06-19 | 1993-06-19 | The medicine of treatment cerebrovascular |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93107114A CN1096680A (en) | 1993-06-19 | 1993-06-19 | The medicine of treatment cerebrovascular |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1096680A true CN1096680A (en) | 1994-12-28 |
Family
ID=4986564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN93107114A Pending CN1096680A (en) | 1993-06-19 | 1993-06-19 | The medicine of treatment cerebrovascular |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1096680A (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7192611B2 (en) * | 2002-03-01 | 2007-03-20 | Unigen Pharmaceuticals, Inc. | Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors |
| US7514469B2 (en) | 2002-04-30 | 2009-04-07 | Unigen Pharmaceuticals, Inc. | Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent |
| US7695743B2 (en) | 2002-04-30 | 2010-04-13 | Unigen Pharmaceuticals, Inc. | Formulation of a mixture of Free-B-Ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments |
| US7972632B2 (en) | 2003-02-28 | 2011-07-05 | Unigen Pharmaceuticals, Inc. | Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors |
| US8568799B2 (en) | 2002-03-22 | 2013-10-29 | Unigen, Inc. | Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from acacia |
| US8771761B2 (en) | 2006-10-12 | 2014-07-08 | Unigen, Inc. | Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria |
| CN104186784A (en) * | 2014-08-15 | 2014-12-10 | 宁国徽煌茶业有限公司 | Vital-energy-regulating and detoxicating tea beverage and preparation method thereof |
| US8945518B2 (en) | 2002-04-30 | 2015-02-03 | Unigen, Inc. | Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions |
| CN104888062A (en) * | 2015-07-05 | 2015-09-09 | 吴优 | Drug for treating liver Yang hyperactivity type hypertensive disease and preparation method therefor |
| US9622964B2 (en) | 2003-04-04 | 2017-04-18 | Unigen, Inc. | Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care |
-
1993
- 1993-06-19 CN CN93107114A patent/CN1096680A/en active Pending
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9061039B2 (en) | 2002-03-01 | 2015-06-23 | Unigen, Inc. | Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors |
| US7192611B2 (en) * | 2002-03-01 | 2007-03-20 | Unigen Pharmaceuticals, Inc. | Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors |
| US8568799B2 (en) | 2002-03-22 | 2013-10-29 | Unigen, Inc. | Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from acacia |
| US9168242B2 (en) | 2002-03-22 | 2015-10-27 | Unigen, Inc. | Isolation of a dual COX-2 and 5-lipdxygenase inhibitor from Acacia |
| US7695743B2 (en) | 2002-04-30 | 2010-04-13 | Unigen Pharmaceuticals, Inc. | Formulation of a mixture of Free-B-Ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments |
| US8034387B2 (en) | 2002-04-30 | 2011-10-11 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments |
| US8652535B2 (en) | 2002-04-30 | 2014-02-18 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments |
| US9849152B2 (en) | 2002-04-30 | 2017-12-26 | Unigen, Inc. | Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent |
| US8945518B2 (en) | 2002-04-30 | 2015-02-03 | Unigen, Inc. | Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions |
| US7674830B2 (en) | 2002-04-30 | 2010-03-09 | Unigen Pharmaceuticals, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
| US9655940B2 (en) | 2002-04-30 | 2017-05-23 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
| US7514469B2 (en) | 2002-04-30 | 2009-04-07 | Unigen Pharmaceuticals, Inc. | Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent |
| US9370544B2 (en) | 2002-04-30 | 2016-06-21 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
| US7972632B2 (en) | 2003-02-28 | 2011-07-05 | Unigen Pharmaceuticals, Inc. | Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors |
| US9622964B2 (en) | 2003-04-04 | 2017-04-18 | Unigen, Inc. | Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care |
| US8771761B2 (en) | 2006-10-12 | 2014-07-08 | Unigen, Inc. | Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria |
| US9623068B2 (en) | 2006-10-12 | 2017-04-18 | Unigen, Inc. | Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria |
| CN104186784A (en) * | 2014-08-15 | 2014-12-10 | 宁国徽煌茶业有限公司 | Vital-energy-regulating and detoxicating tea beverage and preparation method thereof |
| CN104888062A (en) * | 2015-07-05 | 2015-09-09 | 吴优 | Drug for treating liver Yang hyperactivity type hypertensive disease and preparation method therefor |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101361923A (en) | Traditional Chinese medicine for treating rheumatism | |
| CN1895556A (en) | Preparation for treating rheumatosis | |
| CN1096680A (en) | The medicine of treatment cerebrovascular | |
| CN1176680C (en) | Pus drawing out paste for expelling wind and removing obstruction in channels and its preparing method | |
| CN102309723B (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method of ointment thereof | |
| CN1322885C (en) | Plaster medicine composition with multiple purpose for treating affection pain due to dampness | |
| CN1939446A (en) | Externally-applied Chinese-medicinal composition for treating lumbago and skelalgia | |
| CN1313105A (en) | 'Chinese-medicinal pad' and its preparing process | |
| CN100336493C (en) | Bag with Chinese medicine and stone grains for hot compression therapy | |
| CN1233382C (en) | Chinese medicine 'Shentiansu' for internal organ diseases | |
| CN1063088C (en) | Medicine for curing hepatic and gallbladder diseases | |
| CN1308025C (en) | Medicine for treating paraplegia and its preparing method | |
| CN1260209A (en) | Medicine for nephritis--Shenyanling | |
| CN104740450A (en) | Traditional Chinese medicine foot bath powder for treating rheumatism and preparation and application method of traditional Chinese medicine foot bath powder | |
| CN2776353Y (en) | Chinese medicine stone particle formentation therapeutic bag | |
| CN1224416C (en) | Chinese medicine for treating keloid | |
| CN104367679A (en) | Traditional Chinese medicine composition ointment for treating rheumatism and bone diseases | |
| CN1421219A (en) | Chinese medicine for treating women's ovary cancer and uterine myoma | |
| CN108992386A (en) | A kind of functions of removing chloasma face mask of traditional Chinese medicine and preparation method thereof | |
| CN1044566C (en) | Traditional Chinese Medicine "Jinlongkang" for curing rheumatoid disease and its producing method | |
| CN101239109B (en) | Externally-applied plaster for eliminating bony spur and preparation technique | |
| CN101485718B (en) | Medicament for treating rheumatic osteonosus and preparation method thereof | |
| CN1142391A (en) | Oral liquid | |
| CN1218707C (en) | Antilpemic and thrombolytic pill | |
| CN1698801A (en) | Capsule for treating hemiplegia and rheumatism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) |